DOAC therapy was associated with lower odds of mortality (aOR 0.84, 95% CI 0.71-0.98), while VKA therapy showed a numerical trend toward lower odds of mortality (aOR 0.86, 95% CI 0.72–1.01).
← all excerpts
ABSTRACT NUMBER: ESOC2026A2033 THROMBOLYSIS AND OUTCOMES IN ISCHEMIC STROKE IN PATIENTS RECEIVING ORAL ANTICOAGULATION: A POOLED INDIVIDUAL PATIENT DATA ANALYSIS FROM TWO NATIONAL STROKE REGISTRIES
1
—
—